Skip to Content

Gevokizumab Approval Status

  • FDA approved: No
  • Generic name: gevokizumab
  • Company: XOMA Corporation
  • Treatment for: Uveitis

Gevokizumab is a potent monoclonal antibody in development for the treatment of non-infectious uveitis.

Development Status and FDA Approval Process for gevokizumab

Mar  4, 2014XOMA Provides Update on Gevokizumab Proof-of-Concept Program
Feb 24, 2014XOMA Receives Orphan Drug Designation From U.S. FDA for Pyoderma Gangrenosum
Aug 24, 2012XOMA Receives Orphan Drug Designation From U.S. Food & Drug Administration for Gevokizumab

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.